| Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer A Ravi, MD Hellmann, MB Arniella, M Holton, SS Freeman, V Naranbhai, ... Nature Genetics 55 (5), 807-819, 2023 | 93 | 2023 |
| Integrative analysis of checkpoint blockade response in advanced non-small cell lung cancer A Ravi, JF Gainor, MB Arniella, M Holton, SS Freeman, C Stewart, ... bioRxiv, 2022.03. 21.485199, 2022 | 1 | 2022 |
| Immunoproteasome expression and checkpoint blockade response in advanced non-small cell lung cancer V Naranbhai, A Ravi, M Hellmann, M Arniella, M Holton, S Freeman, ... Cancer Research 83 (7_Supplement), 3468-3468, 2023 | | 2023 |
| Clinical characteristics and molecular features of non-small cell lung cancers (NSCLCs) following disease progression on immune checkpoint inhibitors (ICIs). JF Gainor, A Ravi, MM Awad, M Holton, M Arniella, C Stewart, S Freeman, ... Journal of Clinical Oncology 40 (16_suppl), e21178-e21178, 2022 | | 2022 |
